Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Definition of genetic events directing the development of distinct types of brain tumors from postnatal neural stem/progenitor cells.

Hertwig F, Meyer K, Braun S, Ek S, Spang R, Pfenninger CV, Artner I, Prost G, Chen X, Biegel JA, Judkins AR, Englund E, Nuber UA.

Cancer Res. 2012 Jul 1;72(13):3381-92. doi: 10.1158/0008-5472.CAN-11-3525. Epub 2012 Jun 20.

2.

Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro.

Henriquez NV, Forshew T, Tatevossian R, Ellis M, Richard-Loendt A, Rogers H, Jacques TS, Reitboeck PG, Pearce K, Sheer D, Grundy RG, Brandner S.

Cancer Res. 2013 Sep 15;73(18):5834-44. doi: 10.1158/0008-5472.CAN-13-1299. Epub 2013 Jul 25.

3.

Generation of neuronal progenitor cells in response to tumors in the human brain.

Macas J, Ku MC, Nern C, Xu Y, Bühler H, Remke M, Synowitz M, Franz K, Seifert V, Plate KH, Kettenmann H, Glass R, Momma S.

Stem Cells. 2014 Jan;32(1):244-57. doi: 10.1002/stem.1581.

4.

Brain tumor stem cells.

Xie Z.

Neurochem Res. 2009 Dec;34(12):2055-66. doi: 10.1007/s11064-009-0079-5. Epub 2009 Oct 24. Review.

PMID:
19856100
5.

Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.

Thirant C, Bessette B, Varlet P, Puget S, Cadusseau J, Tavares Sdos R, Studler JM, Silvestre DC, Susini A, Villa C, Miquel C, Bogeas A, Surena AL, Dias-Morais A, Léonard N, Pflumio F, Bièche I, Boussin FD, Sainte-Rose C, Grill J, Daumas-Duport C, Chneiweiss H, Junier MP.

PLoS One. 2011 Jan 28;6(1):e16375. doi: 10.1371/journal.pone.0016375.

6.

YB-1 bridges neural stem cells and brain tumor-initiating cells via its roles in differentiation and cell growth.

Fotovati A, Abu-Ali S, Wang PS, Deleyrolle LP, Lee C, Triscott J, Chen JY, Franciosi S, Nakamura Y, Sugita Y, Uchiumi T, Kuwano M, Leavitt BR, Singh SK, Jury A, Jones C, Wakimoto H, Reynolds BA, Pallen CJ, Dunn SE.

Cancer Res. 2011 Aug 15;71(16):5569-78. doi: 10.1158/0008-5472.CAN-10-2805. Epub 2011 Jul 5.

7.

Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors.

Deisch J, Raisanen J, Rakheja D.

Pediatr Dev Pathol. 2011 Sep-Oct;14(5):353-9. doi: 10.2350/10-09-0902-OA.1. Epub 2011 Mar 21.

PMID:
21417895
8.

Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.

Venneti S, Le P, Martinez D, Xie SX, Sullivan LM, Rorke-Adams LB, Pawel B, Judkins AR.

Am J Surg Pathol. 2011 Oct;35(10):1463-72. doi: 10.1097/PAS.0b013e318224d2cd.

PMID:
21921784
9.

The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation.

Liu HK, Wang Y, Belz T, Bock D, Takacs A, Radlwimmer B, Barbus S, Reifenberger G, Lichter P, Schütz G.

Genes Dev. 2010 Apr 1;24(7):683-95. doi: 10.1101/gad.560310.

10.

p53 directly represses Id2 to inhibit the proliferation of neural progenitor cells.

Paolella BR, Havrda MC, Mantani A, Wray CM, Zhang Z, Israel MA.

Stem Cells. 2011 Jul;29(7):1090-101. doi: 10.1002/stem.660.

11.

In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood.

Trojanowski JQ, Fung KM, Rorke LB, Tohyama T, Yachnis AT, Lee VM.

Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):219-39. Review.

PMID:
8086035
12.

Neural stem cells are increased after loss of β-catenin, but neural progenitors undergo cell death.

Holowacz T, Huelsken J, Dufort D, van der Kooy D.

Eur J Neurosci. 2011 Apr;33(8):1366-75. doi: 10.1111/j.1460-9568.2011.07632.x. Epub 2011 Mar 7.

PMID:
21375603
13.

The nuclear receptor TLX is required for gliomagenesis within the adult neurogenic niche.

Zou Y, Niu W, Qin S, Downes M, Burns DK, Zhang CL.

Mol Cell Biol. 2012 Dec;32(23):4811-20. doi: 10.1128/MCB.01122-12. Epub 2012 Oct 1.

14.
15.

MYC expression promotes the proliferation of neural progenitor cells in culture and in vivo.

Fults D, Pedone C, Dai C, Holland EC.

Neoplasia. 2002 Jan-Feb;4(1):32-9.

16.

REST regulates the pool size of the different neural lineages by restricting the generation of neurons and oligodendrocytes from neural stem/progenitor cells.

Covey MV, Streb JW, Spektor R, Ballas N.

Development. 2012 Aug;139(16):2878-90. doi: 10.1242/dev.074765. Epub 2012 Jul 12.

17.

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood.

Bhattacharjee M, Hicks J, Langford L, Dauser R, Strother D, Chintagumpala M, Horowitz M, Cooley L, Vogel H.

Ultrastruct Pathol. 1997 Jul-Aug;21(4):369-78. Review.

PMID:
9206002
18.

Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells.

Sampetrean O, Saga I, Nakanishi M, Sugihara E, Fukaya R, Onishi N, Osuka S, Akahata M, Kai K, Sugimoto H, Hirao A, Saya H.

Neoplasia. 2011 Sep;13(9):784-91.

19.

Genetics of pediatric central nervous system tumors.

Biegel JA.

J Pediatr Hematol Oncol. 1997 Nov-Dec;19(6):492-501. Review.

PMID:
9407934
20.

Lectins as a tool for detecting neural stem/progenitor cells in the adult mouse brain.

Kitada M, Kuroda Y, Dezawa M.

Anat Rec (Hoboken). 2011 Feb;294(2):305-21. doi: 10.1002/ar.21311. Epub 2010 Dec 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk